2016 Heart Valve Summit
A graduate of the Johns Hopkins University School of Medicine, Terry McEnany served for over two decades as a thoracic and cardiovascular surgeon. Terry McEnany MD is a member of the American Association for Thoracic Surgery (AATS), an affiliation that began in 1976. AATS will host its 2016 Heart Valve Summit in October.
The Heart Valve Summit serves as a forum for internists, nurses, physician assistants, and other cardiology and health professionals to explore a wide range of heart disease topics. Hosted by the AATS in conjunction with the American College for Cardiology, the summit’s background lies in treatments for valvular heart disease and now incorporates a number of interdisciplinary areas. Its 2016 course will focus on interactivity and practical decision-making in the heart disease field, and will engage attendees in discussion and debate regarding real-world cases. Attendees can also participate in breakout sessions and network with exhibitors from throughout the industry.
AATS’ 2016 Heart Valve Summit will take place at the Radisson Blu Hotel in Chicago, Illinois, on October 20 to October 22. For more information about the summit, visit aats.org/valve.
Blood Flow Monitoring
Based in the Boston area, Terry McEnany, MD, completed advanced training at Massachusetts General Hospital. Terry McEnany, MD, is experienced in diverse aspects of cardiovascular and thoracic surgery, and stays informed of latest developments in his field.
In early 2016, University of Waterloo, Canada researchers announced the creation of a portable, noninvasive device designed to provide real-time monitoring of blood flow throughout the entire body. The touchless device employs a coded hemodynamic imaging approach to measuring blood flow at several arterial points.
Traditional blood-flow measurement approaches rely on blood-pulse readings at single points in the body. Whole-body imaging, coupled with continuous data collection, offers a much better picture of what is occurring throughout the body. The new photoplethysmographic imaging (PPGI) approach does not involve skin contact, as sensors use ambient and active light fluctuations as a way of measuring changes in local blood volume. The PPGI system has several potential uses, and may be particularly suited to monitoring neonatal intensive care infants and patients with severe burns and extremely contagious diseases.
Terry McEnany, MD, is a thoracic and cardiovascular surgeon with publications in peer-reviewed journals including the American Heart Association’s Circulation, the Rhode Island Medical Journal, and The Annals of Thoracic Surgery. In preparation for his career as a board-certified surgeon, Dr. Terry McEnany earned his medical degree from the Johns Hopkins University School of Medicine.
A recent study by Johns Hopkins researchers investigated the role of oxidative stress, or the body’s ability to neutralize damage caused by free radicals, in heart failure. The study, which was published in The Journal of Clinical Investigation, noted that the process of oxidation interferes with a heart-shielding protein known as PKG. PKG is responsible for controlling biological stressors including elevated blood pressure and inflammation by binding to certain molecules, but oxidation altered the fundamental structure of PKG, impairing its ability to function.
Researchers also experimented with mice that were engineered to have oxidant-resistant PKG, and found that after induced heart failure, they displayed much milder disease than mice with normal PKG. These new findings provide an avenue of research for developing therapies to halt or slow heart failure, a condition that affects an estimated 5.1 million Americans.